</ iframe></noscript> <!-- End Google Tag Manager (noscript) --> <div id="page" class="site"><a aria-label="skip to content" class="skip-link" href="#content">Skip to Content</a> <header class="site-header header-layout-three header-layout-seven header-layout-eight" itemscope itemtype="http://schema.org/WPHeader"> <div class="header-holder"> <div class="header-m" style="background-image:url(https://ddblog.labcorp.com/wp-content/uploads/2021/07/blog-header-1.png)"> <div class="container"> <div class="site-branding" itemscope itemtype="http://schema.org/Organization"> <p class="site-title" itemprop="name"><a href="https://ddblog.labcorp.com/" rel="home" itemprop="url">Insights From Our Labs to Yours</a></p> <p class="site-description" itemprop="description">Labcorp Drug Development Blog</p> </div> </div> </div> </div> <div class="sticky-holder"></div> <div class="header-b"> <div class="container"> <button aria-label="primary menu toggle" id="primary-toggle-button"><i class="fa fa-bars"></i>Navigation</button> <nav id="site-navigation" class="main-navigation" itemscope itemtype="http://schema.org/SiteNavigationElement"> <div class="menu-main-container"><ul id="primary-menu" class="menu"><li id="menu-item-6077" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-6077"><a href="https://ddblog.labcorp.com">Home</a></li> <li id="menu-item-5821" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5821"><a href="https://ddblog.labcorp.com/industry/">Industry</a> <ul class="sub-menu"> <li id="menu-item-5824" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5824"><a href="https://ddblog.labcorp.com/industry/device/">Device</a></li> <li id="menu-item-5825" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5825"><a href="https://ddblog.labcorp.com/industry/drug-development/">Drug</a></li> <li id="menu-item-5822" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5822"><a href="https://ddblog.labcorp.com/industry/chemical/">Chemical</a></li> <li id="menu-item-5823" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5823"><a href="https://ddblog.labcorp.com/industry/crop/">Crop</a></li> </ul> </li> <li id="menu-item-5828" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5828"><a href="https://ddblog.labcorp.com/phase/">Phase</a> <ul class="sub-menu"> <li id="menu-item-5829" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5829"><a href="https://ddblog.labcorp.com/phase/discovery/">Discovery</a></li> <li id="menu-item-5835" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5835"><a href="https://ddblog.labcorp.com/phase/preclinical-nonclinical/">Preclinical/Nonclinical</a></li> <li id="menu-item-5831" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5831"><a href="https://ddblog.labcorp.com/phase/phase-i-iia/">Phase I-IIa</a></li> <li id="menu-item-5832" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5832"><a href="https://ddblog.labcorp.com/phase/phase-iib-iii/">Phase IIb-III</a></li> <li id="menu-item-5833" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5833"><a href="https://ddblog.labcorp.com/phase/pilot/">Pilot</a></li> <li id="menu-item-5834" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5834"><a href="https://ddblog.labcorp.com/phase/pivotal/">Pivotal</a></li> <li id="menu-item-5830" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5830"><a href="https://ddblog.labcorp.com/phase/formulation-packaging/">Formulation, Packaging, etc.</a></li> </ul> </li> <li id="menu-item-5836" class="menu-item menu-item-type-taxonomy menu-item-object-category current-menu-item menu-item-has-children menu-item-5836"><a href="https://ddblog.labcorp.com/molecule-type/" aria-current="page">Molecule Type</a> <ul class="sub-menu"> <li id="menu-item-5837" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5837"><a href="https://ddblog.labcorp.com/molecule-type/biologics/">Biologics</a></li> <li id="menu-item-5841" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5841"><a href="https://ddblog.labcorp.com/molecule-type/small-molecules/">Small Molecules</a></li> <li id="menu-item-5839" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5839"><a href="https://ddblog.labcorp.com/molecule-type/biosimilars/">Biosimilars</a></li> <li id="menu-item-5838" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5838"><a href="https://ddblog.labcorp.com/molecule-type/biomarkers/">Biomarkers</a></li> <li id="menu-item-5840" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5840"><a href="https://ddblog.labcorp.com/molecule-type/cell-gene-therapies/">Cell/Gene Therapies</a></li> </ul> </li> <li id="menu-item-5844" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5844"><a href="https://ddblog.labcorp.com/data-informatics/">Data/Informatics</a> <ul class="sub-menu"> <li id="menu-item-5842" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5842"><a href="https://ddblog.labcorp.com/data-informatics/send/">SEND</a></li> <li id="menu-item-5845" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5845"><a href="https://ddblog.labcorp.com/data-informatics/modeling/">Modeling</a></li> <li id="menu-item-5846" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5846"><a href="https://ddblog.labcorp.com/data-informatics/patient-recruitment/">Patient Recruitment</a></li> <li id="menu-item-5843" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5843"><a href="https://ddblog.labcorp.com/data-informatics/xcellerate/">Xcellerate</a></li> </ul> </li> <li id="menu-item-5827" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-has-children menu-item-5827"><a href="https://ddblog.labcorp.com/about-covance/">About Us</a> <ul class="sub-menu"> <li id="menu-item-5704" class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-5704"><a href="https://ddblog.labcorp.com/about-covance/careers-and-culture/">Careers and Culture</a></li> <li id="menu-item-5792" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5792"><a href="http://response.covance.com/contact-us?elqCampaignId=399&cid=Web_Clk_CVD_blog_megamenunav_0615_399">Contact Us</a></li> <li id="menu-item-5791" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-5791"><a href="https://drugdevelopment.labcorp.com">Labcorp Drug Development</a></li> </ul> </li> </ul></div> </nav><!-- #site-navigation --> <div class="right"> <div class="tools"> <div class="form-section"> <button aria-label="search form toggle" id="btn-search"><i class="fa fa-search"></i></button> <div class="form-holder"> <form role="search" method="get" class="search-form" action="https://ddblog.labcorp.com/"> <label> <span class="screen-reader-text">Search for:</span> <input type="search" class="search-field" placeholder="Search …" value="" name="s" /> </label> <input type="submit" class="search-submit" value="Search" /> </form> </div> </div> </div> <ul class="social-networks"> <li><a href="https://www.linkedin.com/company/labcorpdrugdevelopment" target="_blank" rel="nofollow"><i class="fab fa-linkedin"></i></a></li> <li><a href="https://twitter.com/LabcorpDrugDev" target="_blank" rel="nofollow"><i class="fab fa-twitter-square"></i></a></li> <li><a href="https://www.facebook.com/LabcorpDrugDevelopment" target="_blank" rel="nofollow"><i class="fab fa-facebook"></i></a></li> </ul> </div> </div> </div> </header> <div class="top-bar"> <div class="container"> <header class="page-header"> <h1 class="page-title">Molecule Type</h1> </header><!-- .page-header --> <div class="breadcrumb-wrapper"> <div id="crumbs" itemscope itemtype="http://schema.org/BreadcrumbList"> <span itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a itemprop="item" href="https://ddblog.labcorp.com"><span itemprop="name">Home</span></a> <meta itemprop="position" content="1" /> <span class="separator">/</span> </span><span class="current" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a itemprop="item" href="https://ddblog.labcorp.com/molecule-type/"><span itemprop="name">Molecule Type</span></a><meta itemprop="position" content="2" /> </span></div></div><!-- .breadcrumb-wrapper --> </div> </div> <div class="container main-content"> <div id="content" class="site-content"> <div class="row"> <div id="primary" class="content-area"> <main id="main" class="site-main"> <div class="row"> <article id="post-9091" class="post-9091 post type-post status-publish format-standard has-post-thumbnail hentry category-biomarkers tag-biomarkers tag-precision-medicine latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Serious man is staring at doctor in waiting room" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395-450x300.jpg 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395-90x60.jpg 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395.jpg 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="9097" data-permalink="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/serious-man-is-staring-at-doctor-in-waiting-room/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395.jpg" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"3.2","credit":"Getty Images","camera":"ILCE-7RM2","caption":"Doctor talking to senior patient sitting in waiting room. Serious man is staring at healthcare worker at hospital. They are against window.","created_timestamp":"1550234116","copyright":"","focal_length":"55","iso":"250","shutter_speed":"0.008","title":"Serious man is staring at doctor in waiting room","orientation":"1"}" data-image-title="Serious man is staring at doctor in waiting room" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1136848582-600x400-bf06395.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/&title=Biomarker%20Q&A:%20The%20landscape%20and%20outlook%20for%20precision%20medicine%20in%20neurology" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Biomarker%20Q&A:%20The%20landscape%20and%20outlook%20for%20precision%20medicine%20in%20neurology https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#76492503141c1315024b341f191b17041d130453444627505546454e4d374c534446221e135344461a17181205151706135344461718125344461903021a19191d534446101904534446060413151f051f19185344461b13121f151f18135344461f1853444618130304191a19110f505546454e4d3419120f4b1e020206054c59591212141a1911581a1714151904065815191b594446444459474459141f191b17041d13045b07175b021e135b1a17181205151706135b1718125b1903021a19191d5b1019045b060413151f051f19185b1b13121f151f18135b1f185b18130304191a19110f59" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/" rel="bookmark">Biomarker Q&A: The landscape and outlook for precision medicine in neurology</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-landscape-and-outlook-for-precision-medicine-in-neurology/" rel="bookmark"><time class="entry-date published updated" datetime="2023-01-27T14:40:50-05:00" itemprop="dateModified">Friday, January 27, 2023</time><time class="updated" datetime="2022-12-16T09:54:49-05:00" itemprop="datePublished">Friday, December 16, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Labcorp Drug Development has continued to invest in the technology, innovation and expertise globally to support clients focused on bringing life-changing treatments to patients with neurological diseases. We recently spoke with Robert Martone, Associate Director, Neurology Biomarkers with the Biomarker Solution Center, to learn about the acceleration and expansion of … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-9091 --> <article id="post-9081" class="post-9081 post type-post status-publish format-standard has-post-thumbnail hentry category-biomarkers tag-biomarker tag-precision-medicine latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Female colleagues on a lunch break" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395-450x300.jpg 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395-90x60.jpg 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395.jpg 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="9085" data-permalink="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/female-colleagues-on-a-lunch-break/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395.jpg" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"1.8","credit":"Getty Images","camera":"Canon EOS 5D Mark IV","caption":"Close up of a group of colleagues on a lunch break","created_timestamp":"1601138188","copyright":"","focal_length":"35","iso":"500","shutter_speed":"0.00625","title":"Female colleagues on a lunch break","orientation":"1"}" data-image-title="Female colleagues on a lunch break" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/12/GettyImages-1281127064-600x400-bf06395.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/&title=Biomarker%20Q&A:%20The%20power%20of%20precision%20medicine%20for%20kidney%20disease" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Biomarker%20Q&A:%20The%20power%20of%20precision%20medicine%20for%20kidney%20disease https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#704f2305121a1513044d32191f1d11021b15025542402156534043484b314a554240241815554240001f0715025542401f16554240000215131903191f1e5542401d15141913191e15554240161f025542401b19141e15095542401419031511031556534043484b321f14094d18040400034a5f5f1414121c1f175e1c1112131f02005e131f1d5f424042425f41425f12191f1d11021b15025d01115d0418155d001f0715025d1f165d000215131903191f1e5d1d15141913191e155d161f025d1b19141e15095d141903151103155f" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/" rel="bookmark">Biomarker Q&A: The power of precision medicine for kidney disease</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/12/biomarker-qa-the-power-of-precision-medicine-for-kidney-disease/" rel="bookmark"><time class="entry-date published updated" datetime="2023-01-27T14:41:14-05:00" itemprop="dateModified">Friday, January 27, 2023</time><time class="updated" datetime="2022-12-09T09:50:28-05:00" itemprop="datePublished">Friday, December 9, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Labcorp Drug Development has continued to invest in the technology, capacity and expertise globally to support the evolving and complex analytical needs of our clients. We recently spoke with Katherine T Landschulz, PhD, Sr. Director and Lead Scientist, Cardiovascular and Metabolic Disease, Neurodegeneration at Labcorp Drug Development, to learn about … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-9081 --> <article id="post-9038" class="post-9038 post type-post status-publish format-standard has-post-thumbnail hentry category-cell-gene-therapies category-oncology category-phase-i-iia category-phase-iib-iii tag-adc-antibody tag-antibody-drug-conjugates tag-immune-checkpoint-inhibitors tag-metastatic-breast-cancer tag-metastatic-breast-cancer-drugs tag-metastatic-breast-cancer-immunotherapies tag-metastatic-breast-cancer-indications tag-metastatic-breast-cancer-therapy tag-metastatic-breast-cancer-treatment latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Mature woman with cancer standing with doctor at hospital" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395-450x300.jpg 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395-90x60.jpg 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395.jpg 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="9039" data-permalink="https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/mature-woman-standing-with-doctor-at-hospital/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395.jpg" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"2.8","credit":"Getty Images\/Cavan Images RF","camera":"Canon EOS 5D Mark II","caption":"USA, Ohio, Cincinnati","created_timestamp":"1304414377","copyright":"\u00a9Jonathan Chapman","focal_length":"70","iso":"160","shutter_speed":"0.02","title":"Mature woman standing with doctor at hospital","orientation":"1"}" data-image-title="Mature woman standing with doctor at hospital" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/10/GettyImages-961210118-600x400-bf06395.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/&title=Exploring%20metastatic%20breast%20cancer%20immunotherapies:%20Are%20ADCs%20and%20ICIs%20the%20answer?" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Exploring%20metastatic%20breast%20cancer%20immunotherapies:%20Are%20ADCs%20and%20ICIs%20the%20answer? https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#c4fb97b1a6aea1a7b0f981bcb4a8abb6adaaa3e1f6f4a9a1b0a5b7b0a5b0ada7e1f6f4a6b6a1a5b7b0e1f6f4a7a5aaa7a1b6e1f6f4ada9a9b1aaabb0aca1b6a5b4ada1b7fee1f6f485b6a1e1f6f4858087b7e1f6f4a5aaa0e1f6f48d878db7e1f6f4b0aca1e1f6f4a5aab7b3a1b6fbe2e7f4f7fcff86aba0bdf9acb0b0b4b7feebeba0a0a6a8aba3eaa8a5a6a7abb6b4eaa7aba9ebf6f4f6f6ebf5f4eba1bcb4a8abb6adaaa3e9a9a1b0a5b7b0a5b0ada7e9a6b6a1a5b7b0e9a7a5aaa7a1b6e9ada9a9b1aaabb0aca1b6a5b4ada1b7e9a5b6a1e9a5a0a7b7e9a5aaa0e9ada7adb7e9b0aca1e9a5aab7b3a1b6eb" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/" rel="bookmark">Exploring metastatic breast cancer immunotherapies: Are ADCs and ICIs the answer?</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/10/exploring-metastatic-breast-cancer-immunotherapies-are-adcs-and-icis-the-answer/" rel="bookmark"><time class="entry-date published updated" datetime="2022-10-17T14:41:54-04:00" itemprop="dateModified">Monday, October 17, 2022</time><time class="updated" datetime="2022-10-17T14:41:53-04:00" itemprop="datePublished">Monday, October 17, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Breast cancer is the most common malignancy in women and the second most common cancer worldwide.1 Rates of breast cancer are increasing in many parts of the world, reflecting its association with social and lifestyle factors related to economic development, as well as increases in life expectancy.2 Although the disease … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-9038 --> <article id="post-9026" class="post-9026 post type-post status-publish format-standard has-post-thumbnail hentry category-cell-gene-therapies tag-bionalytical-services tag-cell-gene-therapy tag-cmc tag-ddpcr tag-preclinical-oncology tag-rare-diseases latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Mother and daughter embracing in kitchen" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395-450x300.jpg 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395-90x60.jpg 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395.jpg 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="9027" data-permalink="https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/mother-and-daughter-embracing-in-kitchen/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395.jpg" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"1.6","credit":"Getty Images","camera":"Canon EOS 5D Mark IV","caption":"Mother and daughter embracing in kitchen","created_timestamp":"1518779665","copyright":"","focal_length":"35","iso":"640","shutter_speed":"0.001","title":"Mother and daughter embracing in kitchen","orientation":"1"}" data-image-title="Mother and daughter embracing in kitchen" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/09/GettyImages-924568294-600x400-bf06395.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/&title=Cell%20and%20Gene%20Therapy%20Answers:%20The%20importance%20of%20designing%20trials%20and%20strategies%20with%20the%20end%20goals%20in%20mind" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Cell%20and%20Gene%20Therapy%20Answers:%20The%20importance%20of%20designing%20trials%20and%20strategies%20with%20the%20end%20goals%20in%20mind https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#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" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/" rel="bookmark">Cell and Gene Therapy Answers: The importance of designing trials and strategies with the end goals in mind</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/darby-l-thomas/">Darby L. Thomas, PhD, Director, Cell and Gene Therapy Alliance</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/09/cell-and-gene-therapy-answers-the-importance-of-designing-trials-and-strategies-with-the-end-goals-in-mind/" rel="bookmark"><time class="entry-date published updated" datetime="2023-01-27T14:28:02-05:00" itemprop="dateModified">Friday, January 27, 2023</time><time class="updated" datetime="2022-09-06T14:09:00-04:00" itemprop="datePublished">Tuesday, September 6, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>The cell and gene therapy landscape is experiencing a season of exponential growth within drug development. With more and more assets entering preclinical development every day, Darby Thomas, director in the Cell and Gene Therapy Alliance at Labcorp Drug Development, underscores the importance of designing trials and strategies with the … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-9026 --> <article id="post-9002" class="post-9002 post type-post status-publish format-standard has-post-thumbnail hentry category-cell-gene-therapies category-oncology category-preclinical-nonclinical tag-cell-gene-therapy tag-cmc tag-ddpcr tag-oncology tag-preclinical-oncology tag-rare-diseases latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Two scientists working together in a lab" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt-450x300.png 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt-300x200.png 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt-90x60.png 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt.png 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="9003" data-permalink="https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/blogcgt/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt.png" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="blogcgt" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt-300x200.png" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/08/blogcgt.png" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/&title=Cell%20and%20Gene%20Therapy%20Answers:%20Bioanalytical%20support%20for%20cell%20and%20gene%20therapy" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Cell%20and%20Gene%20Therapy%20Answers:%20Bioanalytical%20support%20for%20cell%20and%20gene%20therapy https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#655a3610070f0006115826000909405755040b0140575522000b00405755310d001704151c405755240b16120017165f405755270c0a040b04091c110c060409405755161015150a1711405755030a1740575506000909405755040b0140575502000b00405755110d001704151c434655565d5e270a011c580d111115165f4a4a010107090a024b090407060a17154b060a084a575557574a555d4a0600090948040b014802000b0048110d001704151c48040b161200171648070c0a040b04091c110c06040948161015150a171148030a17480600090948040b014802000b0048110d001704151c4a" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/" rel="bookmark">Cell and Gene Therapy Answers: Bioanalytical support for cell and gene therapy</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/08/cell-and-gene-therapy-answers-bioanalytical-support-for-cell-and-gene-therapy/" rel="bookmark"><time class="entry-date published updated" datetime="2023-01-27T14:27:37-05:00" itemprop="dateModified">Friday, January 27, 2023</time><time class="updated" datetime="2022-08-15T11:47:12-04:00" itemprop="datePublished">Monday, August 15, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Your source for answers to the complex challenges of cell and gene therapy development. We recently spoke with Daniel Sikkema, executive director of global immunochemistry at Labcorp Drug Development, regarding bioanalytical support for cell and gene therapy modalities. He shared some of the current challenges in cell and gene therapy, … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-9002 --> <article id="post-8707" class="post-8707 post type-post status-publish format-standard has-post-thumbnail hentry category-about-covance category-cell-gene-therapies category-clinical-development category-central-laboratory-services category-decentralized-clinical-trials category-drug-development category-healthcare category-molecule-type category-preclinical-nonclinical category-rare-disease category-therapeutic-area category-uncategorized tag-decentralized-clinical-trials tag-decentralized-clinical-trials-dct latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped-450x300.png" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="" srcset="https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped-450x300.png 450w, https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped-300x200.png 300w, https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped-90x60.png 90w, https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped.png 600w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="8712" data-permalink="https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/resizedandcropped/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped.png" data-orig-size="600,400" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="resizedandcropped" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped-300x200.png" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2022/02/resizedandcropped.png" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/&title=Rare%20Disease%20Day%202022:%20Supporting%20patients,%20celebrating%20advancements" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Rare%20Disease%20Day%202022:%20Supporting%20patients,%20celebrating%20advancements https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#ccf39fb9aea6a9afb8f19eadbea9e9fefc88a5bfa9adbfa9e9fefc88adb5e9fefcfefcfefef6e9fefc9fb9bcbca3beb8a5a2abe9fefcbcadb8a5a9a2b8bfe0e9fefcafa9a0a9aebeadb8a5a2abe9fefcada8baada2afa9a1a9a2b8bfeaeffcfff4f78ea3a8b5f1a4b8b8bcbff6e3e3a8a8aea0a3abe2a0adaeafa3bebce2afa3a1e3fefcfefee3fcfee3beadbea9e1a8a5bfa9adbfa9e1a8adb5e1fefcfefee1bfb9bcbca3beb8a5a2abe1bcadb8a5a9a2b8bfe1afa9a0a9aebeadb8a5a2abe1ada8baada2afa9a1a9a2b8bfe3" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/" rel="bookmark">Rare Disease Day 2022: Supporting patients, celebrating advancements</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2022/02/rare-disease-day-2022-supporting-patients-celebrating-advancements/" rel="bookmark"><time class="entry-date published updated" datetime="2022-11-21T16:22:41-05:00" itemprop="dateModified">Monday, November 21, 2022</time><time class="updated" datetime="2022-02-22T11:55:43-05:00" itemprop="datePublished">Tuesday, February 22, 2022</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>February 28 is Rare Disease Day, a day dear to the hearts of many at Labcorp. The day is observed to raise awareness and give support to the more than 300 million people worldwide living with rare diseases, as well as their family members and caretakers. At the heart of … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-8707 --> <article id="post-8373" class="post-8373 post type-post status-publish format-standard has-post-thumbnail hentry category-cell-gene-therapies category-preclinical-nonclinical tag-cell-therapy tag-ddpcr tag-gene-therapy tag-qpcr latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2021/03/Clinical-Trials-Labs-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Clinical Trials Labs" data-attachment-id="7769" data-permalink="https://ddblog.labcorp.com/2021/03/six-automated-clinical-alerts-you-need-to-increase-efficiency-in-your-clinical-trials/clinical-trials-labs/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2021/03/Clinical-Trials-Labs.jpg" data-orig-size="800,450" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2021/03/Clinical-Trials-Labs-300x169.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2021/03/Clinical-Trials-Labs.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/&title=Cell%20&%20Gene%20Therapy%20Answers:%20Addressing%20Complex%20Analytical%20Needs%20with%20ddPCR/qPCR" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Cell%20&%20Gene%20Therapy%20Answers:%20Addressing%20Complex%20Analytical%20Needs%20with%20ddPCR/qPCR https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#1f204c6a7d757a7c6b225c7a73733a2d2f393c2f2c27243a2d2f587a717a3a2d2f4b777a6d7e6f663a2d2f5e716c687a6d6c253a2d2f5e7b7b6d7a6c6c7671783a2d2f5c70726f737a673a2d2f5e717e73666b767c7e733a2d2f517a7a7b6c3a2d2f68766b773a2d2f7b7b4f5c4d306e4f5c4d393c2f2c27245d707b6622776b6b6f6c2530307b7b7d73707831737e7d7c706d6f317c7072302d2f2d2e302f26307e7b7b6d7a6c6c767178327c70726f737a67327e717e73666b767c7e7332717a7a7b6c3268766b77327b7b6f7c6d326e6f7c6d30" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/" rel="bookmark">Cell & Gene Therapy Answers: Addressing Complex Analytical Needs with ddPCR/qPCR</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/hazel-staton/">Hazel Staton, Lead Scientist, BioPharm CMC at Labcorp Drug Development</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2021/09/addressing-complex-analytical-needs-with-ddpcr-qpcr/" rel="bookmark"><time class="entry-date published updated" datetime="2021-10-08T17:09:50-04:00" itemprop="dateModified">Friday, October 8, 2021</time><time class="updated" datetime="2021-09-20T10:07:41-04:00" itemprop="datePublished">Monday, September 20, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Your source for answers to the complex challenges of cell and gene therapy development. Watch the Video As the rate of cell and gene therapy development increases, Labcorp Drug Development has continued to invest in the technology, capacity and expertise globally to support the evolving and complex analytical needs of … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-8373 --> <article id="post-8340" class="post-8340 post type-post status-publish format-standard has-post-thumbnail hentry category-cell-gene-therapies category-drug-development category-phase-iib-iii tag-cell-gene-therapy tag-cell-therapy tag-gene-therapies tag-precision-medicine latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="6694883_m" srcset="https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-450x300.jpg 450w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-1024x683.jpg 1024w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-768x512.jpg 768w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-1536x1024.jpg 1536w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-2048x1365.jpg 2048w, https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-90x60.jpg 90w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="8343" data-permalink="https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/6694883_m/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m.jpg" data-orig-size="2508,1672" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"6694883 - scientist conducting research taking notes whilst looking through microscope selective focus","created_timestamp":"0","copyright":"18percentgrey\/123RF","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2021/08/6694883_m-1024x683.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/&title=Cell%20&%20Gene%20Therapy%20Answers:%20The%20Evolving%20Cell%20&%20Gene%20Therapy%20Landscape" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Cell%20&%20Gene%20Therapy%20Answers:%20The%20Evolving%20Cell%20&%20Gene%20Therapy%20Landscape https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#3b04684e59515e584f06785e57571e090b1d180b0803001e090b7c5e555e1e090b6f535e495a4b421e090b7a55484c5e4948011e090b6f535e1e090b7e4d54574d52555c1e090b785e57571e090b1d180b0803001e090b7c5e555e1e090b6f535e495a4b421e090b775a555f48585a4b5e1d180b08030079545f4206534f4f4b480114145f5f5957545c15575a595854494b1558545614090b090a140b0314585e5757165c5e555e164f535e495a4b42165a55484c5e4948164f535e165e4d54574d52555c16585e5757165c5e555e164f535e495a4b4216575a555f48585a4b5e14" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/" rel="bookmark">Cell & Gene Therapy Answers: The Evolving Cell & Gene Therapy Landscape</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/marylandfranklin/">Maryland Franklin, Vice President and Enterprise Head of Cell & Gene Therapy at Labcorp Drug Development</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2021/08/cell-gene-therapy-answers-the-evolving-cell-gene-therapy-landscape/" rel="bookmark"><time class="entry-date published updated" datetime="2021-08-05T17:38:26-04:00" itemprop="dateModified">Thursday, August 5, 2021</time><time class="updated" datetime="2021-08-05T17:38:24-04:00" itemprop="datePublished">Thursday, August 5, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Your source for answers to the complex challenges of cell and gene therapy development. We recently sat down with Maryland Franklin, Vice President and Enterprise Head of Cell & Gene Therapy at Labcorp Drug Development, to discuss key considerations for developing cell or gene therapies in today’s quickly expanding pipeline.</p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-8340 --> <article id="post-3565" class="post-3565 post type-post status-publish format-standard has-post-thumbnail hentry category-biosimilars category-drug-development category-preclinical-nonclinical tag-biosimilars latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Biosimilars Covance" srcset="https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene.jpg 2508w, https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-300x200.jpg 300w, https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-768x512.jpg 768w, https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-1024x683.jpg 1024w, https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-450x300.jpg 450w" sizes="(max-width: 450px) 100vw, 450px" data-attachment-id="3567" data-permalink="https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/37957717-microscope-in-medical-laboratory/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene.jpg" data-orig-size="2508,1672" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"37957717 - microscope in medical laboratory","created_timestamp":"0","copyright":"luchschen\/123RF","focal_length":"0","iso":"0","shutter_speed":"0","title":"37957717 - microscope in medical laboratory","orientation":"0"}" data-image-title="Biosimilars Covance" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-300x200.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2018/01/Lab-Scene-1024x683.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/&title=A%20Creative%20Solution%20to%20Address%20the%20Biosimilar%20Boom" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=A%20Creative%20Solution%20to%20Address%20the%20Biosimilar%20Boom https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#536c002631393630276e1276616310213632273a2536766163003c3f26273a3c3d766163273c76616312373721362020766163273b36766163113a3c203a3e3a3f3221766163113c3c3e757063606b68113c372a6e3b27272320697c7c3737313f3c347d3f3231303c21237d303c3e7c616361627c63657c30213632273a25367e203c3f26273a3c3d7e323737213620207e313a3c203a3e3a3f32217e313c3c3e7c" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/" rel="bookmark">A Creative Solution to Address the Biosimilar Boom</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/covance/">Labcorp</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2021/06/creative-solution-address-biosimilar-boom/" rel="bookmark"><time class="entry-date published updated" datetime="2021-07-26T16:28:42-04:00" itemprop="dateModified">Monday, July 26, 2021</time><time class="updated" datetime="2021-06-07T09:27:00-04:00" itemprop="datePublished">Monday, June 7, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>Identifying viable study sites presents a challenge in many clinical trials. Biosimilar development is especially challenging as the number of sponsors preparing to broaden access to today’s blockbuster biologics, by providing lower-cost biosimilar alternative, continues to grow. While this flood of research activity will make a significant improvement for patient … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-3565 --> <article id="post-7733" class="post-7733 post type-post status-publish format-standard has-post-thumbnail hentry category-crop category-preclinical-nonclinical category-vaccine-molecule-type tag-endocrine-disruptor latest_post" itemscope itemtype="https://schema.org/Blog"> <a href="https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" class="post-thumbnail"><img width="450" height="300" src="https://ddblog.labcorp.com/wp-content/uploads/2021/02/Tractor-450x300.jpg" class="attachment-blossom-feminine-cat size-blossom-feminine-cat wp-post-image" alt="Tractor" data-attachment-id="7736" data-permalink="https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/tractor/" data-orig-file="https://ddblog.labcorp.com/wp-content/uploads/2021/02/Tractor.jpg" data-orig-size="642,411" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="" data-image-description="" data-medium-file="https://ddblog.labcorp.com/wp-content/uploads/2021/02/Tractor-300x192.jpg" data-large-file="https://ddblog.labcorp.com/wp-content/uploads/2021/02/Tractor.jpg" /></a> <div class="text-holder"> <header class="entry-header"> <div class="top"> <div class="share"> <i class="fa fa-share-alt"></i>Share <div class="social-networks"> <ul> <li><a href="https://www.linkedin.com/shareArticle?mini=true&url=https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/&title=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements" rel="nofollow" target="_blank"><i class="fa fa-linkedin" aria-hidden="true"></i></a></li><li><a href="https://twitter.com/home?status=Pesticide%20active%20ingredient%20renewal:%20how%20to%20negotiate%20the%20EU%20endocrine%20disruptor%20requirements https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-twitter" aria-hidden="true"></i></a></li><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="nofollow" target="_blank"><i class="fa fa-facebook" aria-hidden="true"></i></a></li><li><a href="/cdn-cgi/l/email-protection#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" rel="nofollow" target="_blank"><i class="fa fa-envelope" aria-hidden="true"></i></a></li> </ul> </div> </div> </div><h2 class="entry-title" itemprop="headline"><a href="https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark">Pesticide active ingredient renewal: how to negotiate the EU endocrine disruptor requirements</a></h2><div class="entry-meta"><span class="byline" itemprop="author" itemscope itemtype="https://schema.org/Person"> by <span class="author vcard" itemprop="name"><a class="url fn n" href="https://ddblog.labcorp.com/author/hyacinth-chin-sue/">Hyacinth Chin Sue, Expert Consultant, CPC Crop Protection</a></span></span><span class="posted-on"><span class="text-on">updated on </span><a href="https://ddblog.labcorp.com/2021/02/pesticide-active-ingredient-renewal-how-to-negotiate-the-eu-endocrine-disruptor-requirements/" rel="bookmark"><time class="entry-date published updated" datetime="2021-06-03T17:41:51-04:00" itemprop="dateModified">Thursday, June 3, 2021</time><time class="updated" datetime="2021-02-15T14:46:30-05:00" itemprop="datePublished">Monday, February 15, 2021</time></a></span></div><!-- .entry-meta --> </header><!-- .entry-header home--> <div class="entry-content" itemprop="text"> <p>ED assessment of active substances in PPPs came into effect in November 2018 in the EU. Insights from EFSA’s assessment of the first 65 actives shows how guidance is applied and how waivers are being used. Read on to find out how to negotiate the ED assessment process and when … </p> </div><!-- .entry-content --> <footer class="entry-footer"> </footer><!-- .entry-footer home--> </div><!-- .text-holder --> </article><!-- #post-7733 --> </div> <div class="pagination"></div> </main><!-- #main --> </div><!-- #primary --> </div><!-- .row/not-found --> </div><!-- #content --> </div><!-- .container/.main-content --> <footer id="colophon" class="site-footer" itemscope itemtype="http://schema.org/WPFooter"> <div class="site-info"> <div class="container"> <span class="copyright">Copyright © 2022 Labcorp All rights reserved.</span> </div> </div> </footer><!-- #colophon --> <button aria-label="go to top" id="blossom-top"> <span><i class="fa fa-angle-up"></i>TOP</span> </button> </div><!-- #page --> <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/all.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/v4-shims.min.js?ver=5.6.3'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/sticky-kit.min.js?ver=1.1.3'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.min.js?ver=2.2.1'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/owl.carousel.aria.min.js?ver=2.0.0'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/jquery.matchHeight.min.js?ver=0.7.2'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/wow.min.js?ver=1.1.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_data = {"lightbox":"","auto":"","loop":"","speed":"3000","animation":"fadeOut","child":"default","sticky":"","sticky_widget":"","header":"eight","url":"https:\/\/ddblog.labcorp.com\/wp-admin\/admin-ajax.php","rtl":""}; /* ]]> */ </script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/custom.min.js?ver=2.3.3'></script> <script type='text/javascript'> /* <![CDATA[ */ var bfp_ajax = {"url":"https:\/\/ddblog.labcorp.com\/wp-admin\/admin-ajax.php","startPage":"1","maxPages":"5","nextLink":"https:\/\/ddblog.labcorp.com\/molecule-type\/page\/2\/","autoLoad":"load_more","loadmore":"Load More Posts","loading":"Loading...","nomore":"No More Post","layouts":"two-col-right","plugin_url":"https:\/\/ddblog.labcorp.com\/wp-content\/plugins"}; /* ]]> */ </script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/themes/blossom-feminine-pro/js/ajax.min.js?ver=2.3.3'></script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-includes/js/wp-embed.min.js?ver=5.4'></script> <script type='text/javascript'> /* <![CDATA[ */ var jetpackCarouselStrings = {"widths":[370,700,1000,1200,1400,2000],"is_logged_in":"","lang":"en","ajaxurl":"https:\/\/ddblog.labcorp.com\/wp-admin\/admin-ajax.php","nonce":"eb9882f0c8","display_exif":"1","display_comments":"1","display_geo":"1","single_image_gallery":"1","single_image_gallery_media_file":"","background_color":"black","comment":"Comment","post_comment":"Post Comment","write_comment":"Write a Comment...","loading_comments":"Loading Comments...","download_original":"View full size <span class=\"photo-size\">{0}<span class=\"photo-size-times\">\u00d7<\/span>{1}<\/span>","no_comment_text":"Please be sure to submit some text with your comment.","no_comment_email":"Please provide an email address to comment.","no_comment_author":"Please provide your name to comment.","comment_post_error":"Sorry, but there was an error posting your comment. Please try again later.","comment_approved":"Your comment was approved.","comment_unapproved":"Your comment is in moderation.","camera":"Camera","aperture":"Aperture","shutter_speed":"Shutter Speed","focal_length":"Focal Length","copyright":"Copyright","comment_registration":"1","require_name_email":"1","login_url":"https:\/\/ddblog.labcorp.com\/wp-login.php?redirect_to=https%3A%2F%2Fddblog.labcorp.com%2F2022%2F12%2Fbiomarker-qa-the-power-of-precision-medicine-for-kidney-disease%2F","blog_id":"1","meta_data":["camera","aperture","shutter_speed","focal_length","copyright"],"local_comments_commenting_as":"<p id=\"jp-carousel-commenting-as\">You must be <a href=\"#\" class=\"jp-carousel-comment-login\">logged in<\/a> to post a comment.<\/p>"}; /* ]]> */ </script> <script type='text/javascript' src='https://ddblog.labcorp.com/wp-content/plugins/jetpack/_inc/build/carousel/jetpack-carousel.min.js?ver=9.1.1'></script> <script type="text/javascript"> if(typeof _satellite !== "undefined"){ _satellite.pageBottom(); } </script> </body> </html>